In the CLL group, the ratios of anti-Gal IgA (p = 0.0004) and anti-Gal IgM (p = 0.0012) to total IgA/IgM were already lower than those in controls. The gene discussed is CD79A; the disease is B-cell chronic lymphocytic leukemia.